Jose Pereira Moura Neto

Prof. Dr. Jose Pereira Moura Neto

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
MBMarcelo Augusto Mota Brito
Marcelo Augusto Mota Brito
HPHenry Maia Peixoto
Henry Maia Peixoto
AAAnne Cristine Gomes de Almeida
Anne Cristine Gomes de Almeida
MOMaria Regina Fernandes de Oliveira
Maria Regina Fernandes de Oliveira
GRGustavo Adolfo Sierra Romero
Gustavo Adolfo Sierra Romero
MLMarcus Vinícius Guimarães de Lacerda
Marcus Vinícius Guimarães de Lacerda
Keywords: Malaria; Plasmodium vivax; Glucose-6-phosphate dehydrogenase deficiency; Care Start G6PD

20 September 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
TMTirza Mesquita
Tirza Mesquita
JJJosé Do Espírito Santo Junior
José Do Espírito Santo Junior
TLThais Carneiro de Lacerda
Thais Carneiro de Lacerda
KQKrys Layane Guimarães Duarte Queiroz
Krys Layane Guimarães Duarte Queiroz
CJCláudio Marcello da Silveira Júnior
Cláudio Marcello da Silveira Júnior
RRRajendranath Ramasawmy
Rajendranath Ramasawmy
Leishmaniaare intracellular protozoan parasites that cause a wide spectrum of clinical manifestations in genetically susceptible individuals with an insufficient or balanced Th1 immune response to eliminate the parasite. MiRNAs play important regulatory role in numerous biological processes including essential cellular functions. miR146-a acts as an inhibitor of interleukin 1 receptor associated kinase 1 (IRAK1) and tumour necrosis factor (TNF) receptor associated factor 6 (TRAF6) present in the toll-like receptors pathway while miR499a modulates TGF-β and TNF signalling pathways. Here, we investigated whetherMIRNA146A rs2910164 and MIRNA499 rs3746444variants are associated with the development ofL.guyanensis(Lg)-cutaneous leishmaniasis (CL). The variantsMIR146Ars2910164 andMIR499Ars3746444 were assessed in 850 patients withLg-CL and 891 healthy controls by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Plasma cytokines were measured using the BioPlex assay. Carriers of rs2910164 CC genotype have 30% higher odds of developing CL (ORadjage/sex= 1.3 [95%CI 0.9–1.8]; Padjage/sex0.14) compared to individuals with the genotype GG (ORadjage/sex= 0.77 [95%CI 0.56–1.0]; Padjage/sex0.14) if exposed toLg-infection. Heterozygous GC individuals also showed lower odds of developing CL (ORadjage/sex= 0.77 [95%CI 0.5–1.1]; Padjage/sex0.09). Homozygosity for the allele C is suggestive of an association with the development ofLg-CL among exposed individuals toLg-infection. However, the odds of developing CL associated with the CC genotype was evident only in male individuals (ORadjage= 1.3 [95% CI = 0.9–2.0]; Padjage= 0.06). Individuals homozygous for the G allele tend to have higher plasma IL-8 and CCL5. Similarly, for theMIR499Ars3746444, an association with the G allele was only observed among male individuals (OR = 1.4 [1.0–1.9]; P = 0.009). In a dominant model, individuals with the G allele (GG-GA) when compared to the AA genotype reveals that carriers of the G allele have 40% elevated odds of developingLg-CL (ORadjage= 1.4 [1.1–1.9]). Individuals with the GG genotype have higher odds of developingLg-CL (ORadjage/sex= 2.0 [95%CI 0.83–5.0]; Padjage= 0.01. Individuals homozygous for the G allele have higher plasma IL-8. Genetic combinations of both variants revealed that male individuals exposed toLgbearing three or four susceptible alleles have higher odds of developingLg-CL (OR = 2.3 [95% CI 1.0–4.7]; p = 0.017). BothMIR146Ars2910164 andMIR499Ars3746444 are associated with the development ofLg-CL and this association is prevalent in male individuals.

1 April 2020 in Revista Brasileira de Medicina do Esporte
Verified
Journal Article
Open access
PDF file
ARAgnelo Weber de Oliveira Rocha
Agnelo Weber de Oliveira Rocha
WNWhendel Mesquita Do Nascimento
Whendel Mesquita Do Nascimento
COCintia Mara da Costa Oliveira
Cintia Mara da Costa Oliveira
JNJose Pereira Moura Neto
Jose Pereira Moura Neto
ONOzanildo Vilaça Do Nascimento
Ozanildo Vilaça Do Nascimento
SFSpartaco Astolfi Filho
Spartaco Astolfi Filho
Introduction: The angiotensin-converting enzyme I-D (ACE) polymorphism gene is one of the most widely investigated genetic variations in sports science. Apparently, allele I is related to endurance sports, while allele D is related to power-strength activities. Nevertheless, studies have presented controversial results when it comes as to its occurrence in a variety of sports. Objective: This study aims to evaluate the frequency of gene ACE polymorphism I-D in professional athletes of collective or individual sports. Methods: Five mL blood were collected from 189 subjects divided into two groups: athletes (AG, n=127, wrestling, taekwondo, soccer, futsal and handball) and non-athletes (NAG, n=62). The athletes group was subdivided by group modalities, into: collective and individual. Both groups were further subdivided into male and female. Thus, we have the groups FAC= collective female, FAI= individual female, MAC= collective male, and MAI= individual male. The statistical analysis was carried out by frequency test, and the Hardy- Weinberg equilibrium by the x² test. Results: The results for the AG group indicated the following frequencies: DD=7%, ID=44% and II=49%. Allele frequency: D=29% and I=71%. For the NAG, the results were: DD=6.5%, ID=45.2% and II=48%. Allele frequency: D=29% and I=71%. The AG genotypic and allele frequencies did not differ statistically from those of the NAG (p= 0.982 and p= 0.984, respectively). However, we noticed that the genotypes II and ID frequencies were significantly higher than those of the DD. Conclusion: It can be concluded that the genotypic and allelic I-D frequencies of the ACE gene do not seem to influence performance in either group or individual sports. ACTN3 genotype frequencies did not vary significantly between male and female control subjects, and overall, there was no significant deviation from Hardy-Weinberg (H-W) equilibrium. Level of evidence I; Diagnostic studies–Investigating diagnostic test.

14 April 2020 in Advances in Hematology
Verified
Journal Article
Open access
PDF file
FAFernanda Cozendey Anselmo
Fernanda Cozendey Anselmo
NFNatália Santos Ferreira
Natália Santos Ferreira
AMAdolfo José da Mota
Adolfo José da Mota
MGMarilda Souza Gonçalves
Marilda Souza Gonçalves
SASérgio Roberto Lopes Albuquerque
Sérgio Roberto Lopes Albuquerque
JNJose Pereira Moura Neto
Jose Pereira Moura Neto
Alpha-thalassemia is highly prevalent in the plural society of Brazil and is a public health problem. There is limited knowledge on its accurate frequency and distribution in the Amazon region. Knowing the frequency of thalassemia and the prevalence of responsible mutations is, therefore, an important step in the understanding and control program. Hematological and molecular data, in addition to serum iron and serum ferritin, from 989 unrelated first-time blood donors from Amazonas Hemotherapy and Hematology Foundation (FHEMOAM) were collected. In this study, the subjects were screened for −α3.7/4.2/20.5, −SEA, −FIL, and −MED deletions. Alpha-thalassemia screening was carried out between 2016 and 2017 among 714 (72.1%) male and 275 (27.9%) female donors. The aims of this analysis were to describe the distribution of various alpha-thalassemia alleles by gender, along with their genotypic interactions, and to illustrate the hematological changes associated with each phenotype. Amongst the patients, 5.35% (n = 53) were diagnosed with deletion –α−3.7 and only one donor with α−4.2 deletion. From the individuals with –α−3.7, 85.8% (n = 46) were heterozygous and 14.20% (n = 7) were homozygous. The frequency of the –α−3.7 deletion was higher in male (5.89%) than in female (4.0%). There is no significant difference in the distribution of –α−3.7 by gender (p=0.217). The –α20.5, −SEA, and −MED deletions were not found. All subjects were analyzed for serum iron and serum ferritin, with 1.04% being iron deficient (n = 5) and none with very high levels of stored iron (>220 µg/dL). Alpha-thalassemia-23.7kb deletion was the most common allele detected in Manaus blood donors, which is a consistent result, once it is the most common type of α-thalassemia found throughout the world. As expected, the mean of hematological data was significantly lower in alpha-thalassemia carriers (p<0.001), mainly homozygous genotype. Leukocytes and platelet count did not differ significantly. Due to the small number of individuals with iron deficiency found among blood donors, the differential diagnosis between the two types of anemia was not possible, even because minor changes were found among hematological parameters with iron deficiency and α-thalassemia. Despite this, the study showed the values of hematological parameters, especially MCV and MCH, are lower in donors with iron deficiency, especially when associated with α-thalassemia, and therefore, it may be useful to discriminate different types of microcytic anaemia. In conclusion, we believed screening for thalassemia trait should be included as part of a standard blood testing before blood donation. It should be noted that this was the first study to perform the screening for alpha deletions in blood donors from the Manaus region, and further studies are required to look at the effects of donated thalassemic blood.

20 March 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
MOMarco Aurélio Almeida de Oliveira
Marco Aurélio Almeida de Oliveira
NMNeila Hiraishi Mallmann
Neila Hiraishi Mallmann
GSGiselle Katiane Bonfim Bacellar de Souza
Giselle Katiane Bonfim Bacellar de Souza
TBThiago de Jesus Bacha
Thiago de Jesus Bacha
ELEmerson Lima
Emerson Lima
JNJose Pereira Moura Neto
Jose Pereira Moura Neto

8 May 2022 in Malaria Journal
Verified
Journal Article
Open access
PDF file
NFNatália S. Ferreira
Natália S. Ferreira
JMJéssica Lorena S. Mathias
Jéssica Lorena S. Mathias
SASérgio Roberto L. Albuquerque
Sérgio Roberto L. Albuquerque
AAAnne Cristine G. Almeida
Anne Cristine G. Almeida
ADAna C. Dantas
Ana C. Dantas
JNJose Pereira Moura Neto
Jose Pereira Moura Neto
Background: Over a third of the world’s population is at risk of Plasmodium vivax-induced malaria. The unique aspect of the parasite’s biology and interactions with the human host make it harder to control and eliminate the disease. Glucose-6-phosphate dehydrogenase (G6PD) deficiency and Duffy-negative blood groups are two red blood cell (RBC) variations that can confer protection against malaria. Methods: Molecular genotyping of G6PD and Duffy variants was performed in 225 unrelated patients (97 with uncomplicated and 128 with severe vivax malaria) recruited at a Reference Centre for Infectious Diseases in Manaus. G6PD and Duffy variants characterizations were performed using Real Time PCR (qPCR) and PCR–RFLP, respectively. Results: The Duffy blood group system showed a phenotypic distribution Fy(a + b−) of 70 (31.1%), Fy(a + b +) 96 (42.7%), Fy(a−b +) 56 (24.9%) and Fy(a−b−) 1 (0.44%.) The genotype FY*A/FY*B was predominant in both uncomplicated (45.3%) and severe malaria (39.2%). Only one Duffy phenotype Fy(a-b) was found and this involved uncomplicated vivax malaria. The G6PD c.202G > A variant was found in 11 (4.88%) females and 18 (8.0%) males, while c.376A > G was found in 20 females (8.88%) and 23 (10.22%) male patients. When combined GATA mutated and c.202G > A and c.376A > G mutated, was observed at a lower frequency in uncomplicated (3.7%) in comparison to severe malaria (37.9%). The phenotype Fy(a−b +) (p = 0.022) with FY*B/FY*B (p = 0.015) genotype correlated with higher parasitaemia. Conclusions: A high prevalence of G6PD c202G > A and c.376A > G and Duffy variants is observed in Manaus, an endemic area for vivax malaria. In addition, this study reports for the first time the Duffy null phenotype Fy(a-b-) in the population of the Amazonas state. Moreover, it is understood that the relationship between G6PD and Duffy variants can modify clinical symptoms in malaria caused by P. vivax and this deserves to be further investigated and explored among this population.